Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 45, 2015 - Issue 20
456
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis of Novel 1,2,3-Triazole-dihydro[3,2-c]chromenones as Acetylcholinesterase Inhibitors

, , , , , & show all
Pages 2311-2318 | Received 21 Apr 2015, Published online: 11 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Amita J. Jivani, Kaushik S. Lunagariya, Khushal M. Kapadiya, Piyush V. Dholaria, Vijay M. Khedkar & Ranjan C. Khunt. (2022) A Step-By-Step Synthesis of S-Methylene Linker Containing Triazole-Benzoxazole Hybrids by Click Chemistry Approach: Anticancer Activity in Human Cells. Analytical Chemistry Letters 12:1, pages 44-57.
Read now
Seyed Esmail Sadat-Ebrahimi, Seyed Mohammad Haghayegh-Zavareh, Saeed Bahadorikhalili, Azadeh Yahya-Meymandi, Mohammad Mahdavi & Mina Saeedi. (2017) Cu(II)-β-cyclodextrin-catalyzed synthesis of spiro[indoline-3,4′-pyrano[3,2-c]chromene]-3′-carbonitrile derivatives. Synthetic Communications 47:24, pages 2324-2329.
Read now

Articles from other publishers (27)

Sorachat Tharamak, Tipanan Wisarutwanit, Weerasak Songoen, Patchreenart Saparpakorn & Wanchai Pluempanupat. (2023) Synthesis and Acetylcholinesterase Inhibitory Evaluation of Coumarin‐Linked Carbazole Derivatives. ChemistrySelect 8:46.
Crossref
Atamjit Singh, Karanvir Singh, Jashandeep Kaur, Ramanpreet Kaur, Aman Sharma, Jasleen Kaur, Uttam Kaur, Renu Chadha & Preet Mohinder Singh Bedi. (2023) Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential. ACS Chemical Neuroscience 14:18, pages 3291-3317.
Crossref
Shah Alam Khan, Mohammad Jawaid Akhtar, Urvashee Gogoi, Dhanalekshmi Unnikrishnan Meenakshi & Aparoop Das. (2023) An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities. Pharmaceuticals 16:2, pages 179.
Crossref
Rakesh Singh, Harpreet Kaur & Pankaj Gupta. 1, 2, 3-triazole based conjugates-potential cholinesterase (AChE and BuChE) and BACE inhibitors for treatment of Alzheimer. 1, 2, 3-triazole based conjugates-potential cholinesterase (AChE and BuChE) and BACE inhibitors for treatment of Alzheimer.
Chandu Anantha Lakshmi Prasanna & Abha Sharma. (2022) Pharmacological Exploration of Triazole-based Therapeutics for Alzheimer’s Disease: An Overview. Current Drug Targets 23:9, pages 933-953.
Crossref
Arruje Hameed, Muhammad Abdul Qayyum, Abdur Rehman, Touseef Ur Rehman, Anwar Ahmad & Tahir Farooq. 2022. More Synthetic Approaches to Nonaromatic Nitrogen Heterocycles. More Synthetic Approaches to Nonaromatic Nitrogen Heterocycles 671 687 .
Asif Husain, Al Balushi K, Md Jawaid Akhtar & Shah Alam Khan. (2021) Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease. Journal of Molecular Structure 1241, pages 130618.
Crossref
Adinath D. Badar, Shubham M. Sulakhe, Mahesh B. Muluk, Naziya N. M. A. Rehman, Prashant P. Dixit, Prafulla B. Choudhari, Giribala M. Bondle & Kishan P. Haval. (2021) Synthesis, Antimicrobial Evaluation and Docking Study of Novel Thiosemicarbazone Clubbed with 1,2,3-Triazoles. Current Bioactive Compounds 17:6.
Crossref
Zahra Haghighijoo, Sara Akrami, Mina Saeedi, Afsaneh Zonouzi, Aida Iraji, Bagher Larijani, Hossein Fakherzadeh, Farshad Sharifi, Seyed Masoud Arzaghi, Mohammad Mahdavi & Najmeh Edraki. (2020) N-Cyclohexylimidazo[1,2-a]pyridine derivatives as multi-target-directed ligands for treatment of Alzheimer's disease. Bioorganic Chemistry 103, pages 104146.
Crossref
Mohamed E. I. Badawy & Saad R. El-Zemity. (2020) 3D Pharmacophore-based Ligand Alignment, Virtual Screening and Molecular Docking Protocols Towards the Discovery of 2-((1H-1,2,4-triazol-1- yl)methyl) Derivatives as Antifungal Inhibitors. Current Bioactive Compounds 16:4, pages 498-513.
Crossref
Zohreh Bakherad, Maryam Mohammadi-Khanaposhtani, Hojjat Sadeghi-Aliabadi, Sepideh Rezaei, Afshin Fassihi, Mohammad Bakherad, Hossein Rastegar, Mahmood Biglar, Lotfollah Saghaie, Bagher Larijani & Mohammad Mahdavi. (2019) New thiosemicarbazide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: Design, synthesis, and biological evaluation. Journal of Molecular Structure 1192, pages 192-200.
Crossref
Maryam Mohammadi-Khanaposhtani, Kiana Fahimi, Elahe Karimpour-Razkenari, Maliheh Safavi, Mohammad Mahdavi, Mina Saeedi & Tahmineh Akbarzadeh. (2019) Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-triazole-1,2,4- Oxadiazole Hybrids as Potent Anti-breast Cancer Agents. Letters in Drug Design & Discovery 16:7, pages 818-824.
Crossref
Mohammad Mahdavi, Roshanak Hariri, Seyedeh Sara Mirfazli, Hania Lotfian, Arezoo Rastergari, Omidreza Firuzi, Najmeh Edraki, Bagher Larijani, Tahmineh Akbarzadeh & Mina Saeedi. (2019) Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti‐Alzheimer's Agents. Chemistry & Biodiversity 16:4.
Crossref
D.S. Bhagat, S.G. Pande, M.V. Katariya, R.P. Pawar & P.S. Kendrekar. (2019) Microwave Assisted One Pot Synthesis of 3,4-Dihydropyrano[c]chromene Derivatives using [Emim]OH Ionic Liquid as Novel Catalyst. Asian Journal of Chemistry 31:4, pages 829-833.
Crossref
Arezoo Rastegari, Hamid Nadri, Mohammad Mahdavi, Alireza Moradi, Seyedeh Sara Mirfazli, Najmeh Edraki, Farshad Homayouni Moghadam, Bagher Larijani, Tahmineh Akbarzadeh & Mina Saeedi. (2019) Design, synthesis and anti-Alzheimer’s activity of novel 1,2,3-triazole-chromenone carboxamide derivatives. Bioorganic Chemistry 83, pages 391-401.
Crossref
Mina Saeedi, Maryam Mohammadi-Khanaposhtani, Parvaneh Pourrabia, Nima Razzaghi, Reza Ghadimi, Somaye Imanparast, Mohammad Ali Faramarzi, Fatemeh Bandarian, Ensieh Nasli Esfahani, Maliheh Safavi, Hossein Rastegar, Bagher Larijani, Mohammad Mahdavi & Tahmineh Akbarzadeh. (2019) Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study. Bioorganic Chemistry 83, pages 161-169.
Crossref
Bilqees Sameem, Mina Saeedi, Mohammad Mahdavi, Hamid Nadri, Fahimeh Vafadarnejad & Mohsen Amini. (2018) Synthesis and Characterization of Novel Phthalimide‐pyrano[3,2‐ c ]chromene and Phthalimide‐pyrano‐2‐one Hybrids . Journal of Heterocyclic Chemistry 55:7, pages 1678-1684.
Crossref
Mohammad Mahdavi, Arsalan Ashtari, Mahsima Khoshneviszadeh, Sara Ranjbar, Ameneh Dehghani, Tahmineh Akbarzadeh, Bagher Larijani, Mehdi Khoshneviszadeh & Mina Saeedi. (2018) Synthesis of New Benzimidazole‐1,2,3‐triazole Hybrids as Tyrosinase Inhibitors. Chemistry & Biodiversity 15:7.
Crossref
T. Jency Mohan & D. Bahulayan. (2017) Design, synthesis and fluorescence property evaluation of blue emitting triazole-linked chromene peptidomimetics. Molecular Diversity 21:3, pages 585-596.
Crossref
Mina Saeedi, Maliheh Safavi, Elahe Karimpour-Razkenari, Mohammad Mahdavi, Najmeh Edraki, Farshad Homayouni Moghadam, Mahnaz Khanavi & Tahmineh Akbarzadeh. (2017) Synthesis of novel chromenones linked to 1,2,3-triazole ring system: Investigation of biological activities against Alzheimer’s disease. Bioorganic Chemistry 70, pages 86-93.
Crossref
Zahra Najafi, Mohammad Mahdavi, Mina Saeedi, Elahe Karimpour-Razkenari, Raymond Asatouri, Fahimeh Vafadarnejad, Farshad Homayouni Moghadam, Mahnaz Khanavi, Mohammad Sharifzadeh & Tahmineh Akbarzadeh. (2017) Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors. European Journal of Medicinal Chemistry 125, pages 1200-1212.
Crossref
Roshanak Hariri, Zahra Afshar, Mohammad Mahdavi, Maliheh Safavi, Mina Saeedi, Zahra Najafi, Reyhaneh Sabourian, Elahe Karimpour‐Razkenari, Najmeh Edraki, Farshad Homayouni Moghadam, Abbas Shafiee, Mahnaz Khanavi & Tahmineh Akbarzadeh. (2016) Novel Tacrine‐Based Pyrano[3’,4’:5,6]pyrano[2,3‐ b ]quinolinones: Synthesis and Cholinesterase Inhibitory Activity . Archiv der Pharmazie 349:12, pages 915-924.
Crossref
Zahra Najafi, Mina Saeedi, Mohammad Mahdavi, Reyhaneh Sabourian, Mahnaz Khanavi, Maliheh Barazandeh Tehrani, Farshad Homayouni Moghadam, Najmeh Edraki, Elahe Karimpor-Razkenari, Mohammad Sharifzadeh, Alireza Foroumadi, Abbas Shafiee & Tahmineh Akbarzadeh. (2016) Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids. Bioorganic Chemistry 67, pages 84-94.
Crossref
Mohammad Mahdavi, Samira Mohammadi-Izad, Mina Saeedi, Maliheh Safavi, Seyed Esmaeil Sadat Ebrahimi, Alireza Foroumadi & Abbas Shafiee. (2016) Synthesis and cytotoxicity of novel chromenone derivatives bearing 4-nitrophenoxy phenyl acryloyl moiety. Journal of the Iranian Chemical Society 13:6, pages 1139-1144.
Crossref
Mina Saeedi, Maedeh Golipoor, Mohammad Mahdavi, Alireza Moradi, Hamid Nadri, Saeed Emami, Alireza Foroumadi & Abbas Shafiee. (2016) Phthalimide‐Derived N ‐Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti‐Alzheimer's Disease Agents . Archiv der Pharmazie 349:4, pages 293-301.
Crossref
Mohammad Mahdavi, Hosein Lijan, Saeed Bahadorikhalili, Leila Ma’mani, Parviz Rashidi Ranjbar & Abbas Shafiee. (2016) Copper supported β-cyclodextrin grafted magnetic nanoparticles as an efficient recyclable catalyst for one-pot synthesis of 1-benzyl-1H-1,2,3-triazoldibenzodiazepinone derivatives via click reaction. RSC Advances 6:34, pages 28838-28843.
Crossref
Clementina M.M. Santos & Artur M.S. Silva. 2016. 523 578 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.